Subscribe to the newsletter

Publications

Latest publications

Load previous publications
  • June 16, 2016

    Chemo-genomic interrogation of CEBPA mutated AML reveals recurrent CSF3R mutations and subgroup sensitivity to JAK inhibitors.

    Lavallée VP, Krosl J, Lemieux S, Boucher G, Gendron P, Pabst C, Boivin I, Marinier A, Guidos CJ, Meloche S, Hébert J, Sauvageau G
    Blood 2016-06-16 ;127( 24 ):3054-61

  • June 13, 2016

    Inhibition of Dopamine Receptor D4 Impedes Autophagic Flux, Proliferation, and Survival of Glioblastoma Stem Cells.

    Dolma S, Selvadurai HJ, Lan X, Lee L, Kushida M, Voisin V, Whetstone H, So M, Aviv T, Park N, Zhu X, Xu C, Head R, Rowland KJ, Bernstein M, Clarke ID, Bader G, Harrington L, Brumell JH, Tyers M, Dirks PB
    Cancer Cell 2016-06-13 ;29( 6 ):859-73

  • June 7, 2016

    Heterogeneous Nuclear Ribonucleoprotein L is required for the survival and functional integrity of murine hematopoietic stem cells.

    Gaudreau MC, Grapton D, Helness A, Vadnais C, Fraszczak J, Shooshtarizadeh P, Wilhelm B, Robert F, Heyd F, Möröy T
    Sci Rep 2016-06-07 ;6:27379

  • June 3, 2016

    Transcriptome analysis of G protein-coupled receptors in distinct genetic subgroups of acute myeloid leukemia: identification of potential disease-specific targets.

    Maiga A, Lemieux S, Pabst C, Lavallée VP, Bouvier M, Sauvageau G, Hébert J
    Blood Cancer J 2016-06-03 ;6( 6 ):e431

  • June 1, 2016

    Thymic Mesenchymal Cells Have a Distinct Transcriptomic Profile.

    Patenaude J, Perreault C
    J. Immunol. 2016-06-01 ;196( 11 ):4760-70

  • June 1, 2016

    Proteogenomic-based discovery of minor histocompatibility antigens with suitable features for immunotherapy of hematologic cancers.

    Granados DP, Rodenbrock A, Laverdure JP, Côté C, Caron-Lizotte O, Carli C, Pearson H, Janelle V, Durette C, Bonneil E, Roy DC, Delisle JS, Lemieux S, Thibault P, Perreault C
    Leukemia 2016-06-01 ;30( 6 ):1344-54

  • June 1, 2016

    Wound dehiscence in a sample of 1 776 cystectomies: identification of predictors and implications for outcomes.

    Meyer CP, Rios Diaz AJ, Dalela D, Hanske J, Pucheril D, Schmid M, Trinh VQ, Sammon JD, Menon M, Chun FK, Noldus J, Fisch M, Trinh VQ
    BJU Int 2016-06-01 ;117( 6B ):E95-E101

  • May 26, 2016

    Rapid Discovery and Structure-Activity Relationships of Pyrazolopyrimidines That Potently Suppress Breast Cancer Cell Growth via SRC Kinase Inhibition with Exceptional Selectivity over ABL Kinase.

    Fraser C, Dawson JC, Dowling R, Houston DR, Weiss JT, Munro AF, Muir M, Harrington L, Webster SP, Frame MC, Brunton VG, Patton EE, Carragher NO, Unciti-Broceta A
    J. Med. Chem. 2016-05-26 ;59( 10 ):4697-710

Load more publications